|
Joint Fellowship Program
|
Training Initiative
|
FDA
|
NCI
|
The objective of the NCI-FDA Joint Fellowship Training Program is to train a cadre of scientists in research and research-related regulatory review, policies, and regulations so that they develop a skill set that bridge the two disparate processes. Fellows will learn to build awareness of regulatory requirements into the early stages of the medical product development process and develop strategies to improve planning throughout research and regulatory review.
|
|
Kaposi Sarcoma and HHV8 in Sickle Cell and Other Ugandan Populations
|
Research Initiative
|
CDC
|
NCI
|
Epidemiological studies are being conducted to assess small-area variation of HHV8 and to learn about socio-demographical and environmental risk factors for HHV8 and Kaposi sarcoma in Uganda.
|
|
Kidney, Urologic, & Hematologic Diseases Interagency Coordinating Committee
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, FDA, HRSA, IHS
|
NIDDK, NCCIH, NCI, NHLBI, NIA, NICHD, NINDS
|
The Kidney, Urologic, and Hematologic Diseases Interagency Coordinating Committee (KUHICC) encourages cooperation, communication, and collaboration among all Federal agencies involved in kidney, urology, and hematology research and other activities. Public Law 99-158 created the KUHICC in 1987 and emphasized the importance of interagency coordinating meetings. Meetings focus on interagency collaboration to elicit ideas from meeting participants to enhance current research directions within the National Institutes of Health and to form partnerships among agencies.
|
|
Laboratory-Developed Tests (LDT) Interagency Task Force
|
Other
|
CDC, CMS, FDA
|
OD/OSP, NLM
|
The Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS) put together an interagency task force to expand their collaboration around oversight of laboratory-developed tests (LDTs). FDA issued draft guidance in October 2014 for overseeing the quality of LDTs, proposing that the FDA oversee the tests alongside CMS, which regulates labs through the Clinical Laboratory Improvement Amendments (CLIA).
|
|
Leadership Forums in Cancer Control Planning
|
Meeting/ Workshop
|
CDC
|
NCI
|
The goal of the Cancer Control Leadership Forum Program is to increase the capacity of participating countries from target regions to initiate or enhance cancer control planning and implementation through a multi-sectoral approach. The three-day Forum is the focal point of a three-part process spanning approximately 18 months and is an opportunity for each country to develop an action plan to move their cancer control planning efforts forward and to exchange experiences about creating and implementing comprehensive cancer control plans with other countries in the region.
|
|
Leprosy Research Support in Armadillos (Dasypus Novemcinctus)
|
Other
|
HRSA
|
NIAID
|
The Leprosy Research Support and Maintenance of an Armadillo Colony – Post Genome Era interagency agreement provides standardized research reagents to investigators worldwide to assist in the development of skin test antigens used to detect leprosy. This agreement supports collaborative research to continuously improve biochemical, microbiological and immunological models for leprosy research in an effort to provide the most up-to-date resource and expertise for mycobacterial researchers.
|
|
Library of Integrated Network-based Cellular Signatures (LINCS)
|
Research Initiative
|
FDA
|
OD/DPCPSI, NHGRI, NHLBI, OD/DPCPSI/OSC
|
The Library of Integrated Network-based Cellular Signatures (LINCS) program is developing a library of data at the cellular level that describes how different types of cells respond to a variety of agents that disrupt normal cellular functions, called “perturbagens.” This library may help us better understand normal and diseased conditions in cells and how to alter them. In FY2016, the LINCS program discussed with the Food and Drug Administration (FDA) how LINCS data may be used to predict the toxicity of drugs in cardiac (heart) cells.
|
|
Linkage to Care Committee for Adolescents with HIV/AIDS
|
Committee, Work group, Advisory group, or Task Force
|
CDC, HRSA
|
NICHD
|
The purpose of this committee is to collaborate with other HHS agencies to improve the outcome of adolescents with HIV/AIDS.
|
|
Logical Observation Identifiers Names and Codes (LOINC)
|
Resource Development
|
AHRQ, CDC, CMS, HRSA, IHS, OS
|
NLM
|
This activity supports the maintenance, distribution, and continued development of LOINC®, a set of universal codes and names to identify laboratory and other clinical observations which facilitates the exchange and pooling of clinical results for clinical care, outcomes management, public health and research. The Regenstrief Institute, Inc., an internationally renowned healthcare and informatics research organization, maintains the LOINC database and supporting documentation, and the RELMA mapping program.
|
|
Long-term Oxygen Treatment Trial
|
Research Initiative
|
CMS
|
NHLBI
|
The Long-term Oxygen Treatment Trial (LOTT) is a randomized controlled clinical trial to assess the efficacy of around-the-clock, supplemental oxygen therapy in subjects with chronic obstructive pulmonary disease and moderately severe hypoxemia. NHLBI administered and oversaw the study, and Medicare covered the costs of items and medical services that are generally available through that program to beneficiaries enrolled in the trial.
|